{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T11:34:42Z","timestamp":1772537682950,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T00:00:00Z","timestamp":1632787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T00:00:00Z","timestamp":1632787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s00228-021-03221-x","type":"journal-article","created":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T07:08:59Z","timestamp":1632812939000},"page":"279-286","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Investigation of the risk factors of vomiting during linezolid therapy: a retrospective observational study"],"prefix":"10.1007","volume":"78","author":[{"given":"Takezo","family":"Tsutsumi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shungo","family":"Imai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Kashiwagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuru","family":"Sugawara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4325-0785","authenticated-orcid":false,"given":"Yoh","family":"Takekuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,28]]},"reference":[{"key":"3221_CR1","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1093\/cid\/ciq146","volume":"52","author":"Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, Kaplan SL, Karchmer AW, Levine DP, Murray BE, J Rybak M, Talan DA, Chambers HF, Infectious Diseases Society of America","year":"2011","unstructured":"Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, Kaplan SL, Karchmer AW, Levine DP, Murray BE, J Rybak M, Talan DA, Chambers HF, Infectious Diseases Society of America (2011) Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 52:e18\u2013e55. https:\/\/doi.org\/10.1093\/cid\/ciq146","journal-title":"Clin Infect Dis"},{"key":"3221_CR2","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2147\/IDR.S54125","volume":"8","author":"T O\u2019Driscoll","year":"2015","unstructured":"O\u2019Driscoll T, Crank CW (2015) Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management. Infect Drug Resist 8:217\u2013230. https:\/\/doi.org\/10.2147\/IDR.S54125","journal-title":"Infect Drug Resist"},{"key":"3221_CR3","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ijid.2019.02.005","volume":"81","author":"AK Thabit","year":"2019","unstructured":"Thabit AK, Fatani DF, Bamakhrama MS, Barnawi OA, Basudan LO, Alhejaili SF (2019) Antibiotic penetration into bone and joints: an updated review. Int J Infect Dis 81:128\u2013136. https:\/\/doi.org\/10.1016\/j.ijid.2019.02.005","journal-title":"Int J Infect Dis"},{"key":"3221_CR4","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1128\/AAC.47.6.1824-1831.2003","volume":"47","author":"E Rubinstein","year":"2003","unstructured":"Rubinstein E, Isturiz R, Standiford HC, Smith LG, Oliphant TH, Cammarata S, Hafkin B, Le V, Remington J (2003) Worldwide assessment of linezolid\u2019s clinical safety and tolerability: comparator-controlled Phase III studies. Antimicrob Agents Chemother 47:1824\u20131831. https:\/\/doi.org\/10.1128\/AAC.47.6.1824-1831.2003","journal-title":"Antimicrob Agents Chemother"},{"key":"3221_CR5","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1128\/AAC.03688-14","volume":"59","author":"AF Shorr","year":"2015","unstructured":"Shorr AF, Lodise TP, Corey GR, De Anda C, Fang E, Das AF, Prokocimer P (2015) Analysis of the Phase 3 ESTABLISH trials of tedizolid versus linezolid in acute bacterial skin and skin structure infections. Antimicrob Agents Chemother 59:864\u2013871. https:\/\/doi.org\/10.1128\/AAC.03688-14","journal-title":"Antimicrob Agents Chemother"},{"key":"3221_CR6","doi-asserted-by":"publisher","unstructured":"Li Y, Xu W (2018) Efficacy and safety of linezolid compared with other treatments for skin and soft tissue infections: a meta-analysis. Biosci Rep. 38:BSR20171125. https:\/\/doi.org\/10.1042\/BSR20171125","DOI":"10.1042\/BSR20171125"},{"key":"3221_CR7","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1183\/09031936.00035114","volume":"45","author":"S Tang","year":"2015","unstructured":"Tang S, Yao L, Hao X, Zhang X, Liu G, Liu X, Wu M, Zen L, Sun H, Liu Y, Gu J, Lin F, Wang X, Zhang Z (2015) Efficacy, safety and tolerability of linezolid for the treatment of XDR-TB: a study in China. Eur Respir J 45:161\u2013170. https:\/\/doi.org\/10.1183\/09031936.00035114","journal-title":"Eur Respir J"},{"key":"3221_CR8","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1248\/yakushi.19-00010","volume":"139","author":"T Tsutsumi","year":"2019","unstructured":"Tsutsumi T, Imai S, Yamada K, Yamada T, Kasashi K, Kobayashi M, Iseki K (2019) Verification of relationship between administration of linezolid and vomiting. Yakugaku Zasshi 139:1055\u20131061. https:\/\/doi.org\/10.1248\/yakushi.19-00010","journal-title":"Yakugaku Zasshi"},{"key":"3221_CR9","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1093\/jac\/dkt133","volume":"68","author":"Y Nukui","year":"2013","unstructured":"Nukui Y, Hatakeyama S, Okamoto K, Yamamoto T, Hisaka A, Suzuki H, Yata N, Yotsuyanagi H, Moriya K (2013) High plasma linezolid concentration and impaired renal function affect development of linezolid-induced thrombocytopenia. J Antimicrob Chemother 68:2128\u20132133. https:\/\/doi.org\/10.1093\/jac\/dkt133","journal-title":"J Antimicrob Chemother"},{"key":"3221_CR10","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1177\/0091270009337947","volume":"49","author":"S Abe","year":"2009","unstructured":"Abe S, Chiba K, Cirincione B, Grasela TH, Ito K, Suwa T (2009) Population pharmacokinetic analysis of linezolid in patients with infectious disease: application to lower body weight and elderly patients. J Clin Pharmacol 49:1071\u20131078. https:\/\/doi.org\/10.1177\/0091270009337947","journal-title":"J Clin Pharmacol"},{"key":"3221_CR11","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.bbrc.2011.05.075","volume":"409","author":"R Mahesh","year":"2011","unstructured":"Mahesh R, Jindal A, Gautam B, Bhatt S, Pandey D (2011) Evaluation of anti-depressant-like activity of linezolid, an oxazolidinone class derivative \u2014 an investigation using behavioral tests battery of depression. Biochem Biophys Res Commun 409:723\u2013726. https:\/\/doi.org\/10.1016\/j.bbrc.2011.05.075","journal-title":"Biochem Biophys Res Commun"},{"key":"3221_CR12","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1592\/phco.26.12.1784","volume":"26","author":"V Huang","year":"2006","unstructured":"Huang V, Gortney JS (2006) Risk of serotonin syndrome with concomitant administration of linezolid and serotonin agonists. Pharmacotherapy 26:1784\u20131793. https:\/\/doi.org\/10.1592\/phco.26.12.1784","journal-title":"Pharmacotherapy"},{"key":"3221_CR13","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/s0895-4356(96)00236-3","volume":"49","author":"P Peduzzi","year":"1996","unstructured":"Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR (1996) A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 49:1373\u20131379. https:\/\/doi.org\/10.1016\/s0895-4356(96)00236-3","journal-title":"J Clin Epidemiol"},{"key":"3221_CR14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000180580","volume":"16","author":"DW Cockcroft","year":"1976","unstructured":"Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31\u201341. https:\/\/doi.org\/10.1159\/000180580","journal-title":"Nephron"},{"key":"3221_CR15","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/jcpt.12681","volume":"43","author":"P Ioannou","year":"2018","unstructured":"Ioannou P, Stavroulaki M, Mavrikaki V, Papakitsou I, Panagiotakis S (2018) A case of severe hyponatremia due to linezolid-induced SIADH. J Clin Pharm Ther 43:434\u2013436. https:\/\/doi.org\/10.1111\/jcpt.12681","journal-title":"J Clin Pharm Ther"},{"key":"3221_CR16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s40780-018-0123-1","volume":"4","author":"S Hashimoto","year":"2018","unstructured":"Hashimoto S, Honda K, Fujita K, Miyachi Y, Isoda K, Misaka K, Suga Y, Kato S, Tsuchiya H, Kato Y, Okajima M, Taniguchi T, Shimada T, Sai Y (2018) Effect of coadministration of rifampicin on the pharmacokinetics of linezolid: clinical and animal studies. J Pharm Health Care Sci 4:27. https:\/\/doi.org\/10.1186\/s40780-018-0123-1","journal-title":"J Pharm Health Care Sci"},{"key":"3221_CR17","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1213\/ANE.0000000000000002","volume":"118","author":"Gan TJ, Diemunsch P, Habib AS, Kovac A, Kranke P, Meyer TA, Watcha M, Chung F, Angus S, Apfel CC, Bergese SD, Candiotti KA, Chan MT, Davis PJ, Hooper VD, Lagoo-Deenadayalan S, Myles P, Nezat G, Philip BK, Tram\u00e8r MR, Society for Ambulatory Anesthesia","year":"2014","unstructured":"Gan TJ, Diemunsch P, Habib AS, Kovac A, Kranke P, Meyer TA, Watcha M, Chung F, Angus S, Apfel CC, Bergese SD, Candiotti KA, Chan MT, Davis PJ, Hooper VD, Lagoo-Deenadayalan S, Myles P, Nezat G, Philip BK, Tram\u00e8r MR, Society for Ambulatory Anesthesia (2014) Consensus guidelines for the management of postoperative nausea and vomiting. Anesth Analg 118:85\u2013113. https:\/\/doi.org\/10.1213\/ANE.0000000000000002","journal-title":"Anesth Analg"},{"key":"3221_CR18","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1056\/NEJMra1515442","volume":"374","author":"RM Navari","year":"2016","unstructured":"Navari RM, Aapro M (2016) Antiemetic prophylaxis for chemotherapy-induced nausea and vomiting. N Engl J Med 374:1356\u20131367. https:\/\/doi.org\/10.1056\/NEJMra1515442","journal-title":"N Engl J Med"},{"key":"3221_CR19","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1007\/s00134-014-3210-2","volume":"40","author":"G Spasovski","year":"2014","unstructured":"Spasovski G, Vanholder R, Allolio B, Annane D, Ball S, Bichet D, Decaux G, Fenske W, Hoorn EJ, Ichai C, Joannidis M, Soupart A, Zietse R, Haller M, van der Veer S, Van Biesen W, Nagler E (2014) Clinical practice guideline on diagnosis and treatment of hyponatraemia. Intensive Care Med 40:320\u2013331. https:\/\/doi.org\/10.1007\/s00134-014-3210-2","journal-title":"Intensive Care Med"},{"key":"3221_CR20","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1248\/bpb.b16-00418","volume":"39","author":"R Tanaka","year":"2016","unstructured":"Tanaka R, Suzuki Y, Takumi Y, Iwao M, Sato Y, Hashinaga K, Hiramatsu K, Kadota JI, Itoh H (2016) A retrospective analysis of risk factors for linezolid-associated hyponatremia in Japanese patients. Biol Pharm Bull 39:1968\u20131973. https:\/\/doi.org\/10.1248\/bpb.b16-00418","journal-title":"Biol Pharm Bull"},{"key":"3221_CR21","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.jiac.2020.08.017","volume":"27","author":"Y Nishi","year":"2021","unstructured":"Nishi Y, Ogami C, Tsuji Y, Kawasuji H, Yamada H, Kawai S, Sakamaki I, To H, Yamamoto Y (2021) Evaluation of the relationship between linezolid exposure and hyponatremia. J Infect Chemother 27:165\u2013171. https:\/\/doi.org\/10.1016\/j.jiac.2020.08.017","journal-title":"J Infect Chemother"},{"key":"3221_CR22","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE) v5.0, National Cancer Institute. https:\/\/www.nih.gov\/ Accessed 27 Nov\u00a02017"},{"key":"3221_CR23","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2174\/1871524914666141226103135","volume":"14","author":"KE Yoest","year":"2014","unstructured":"Yoest KE, Cummings JA, Becker JB (2014) Estradiol, dopamine and motivation. Cent Nerv Syst Agents Med Chem 14:83\u201389. https:\/\/doi.org\/10.2174\/1871524914666141226103135","journal-title":"Cent Nerv Syst Agents Med Chem"},{"key":"3221_CR24","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.brainres.2009.12.093","volume":"1321","author":"C Chavez","year":"2010","unstructured":"Chavez C, Hollaus M, Scarr E, Pavey G, Gogos A, van den Buuse M (2010) The effect of estrogen on dopamine and serotonin receptor and transporter levels in the brain: an autoradiography study. Brain Res 1321:51\u201359. https:\/\/doi.org\/10.1016\/j.brainres.2009.12.093","journal-title":"Brain Res"},{"key":"3221_CR25","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1056\/NEJMoa032196","volume":"350","author":"CC Apfel","year":"2004","unstructured":"Apfel CC, Korttila K, Abdalla M, Kerger H, Turan A, Vedder I, Zernak C, Danner K, Jokela R, Pocock SJ, Trenkler S, Kredel M, Biedler A, Sessler DI, Roewer N, Investigators IMPACT (2004) A factorial trial of six interventions for the prevention of postoperative nausea and vomiting. N Engl J Med 350:2441\u20132451. https:\/\/doi.org\/10.1056\/NEJMoa032196","journal-title":"N Engl J Med"},{"key":"3221_CR26","unstructured":"Zyvox\u00ae package insert, U.S Food & Drug Administration. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2008\/021130s016,021131s013,021132s014lbl.pdf Accessed 8 May 2020"},{"key":"3221_CR27","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1080\/14740338.2017.1335305","volume":"16","author":"A Santini","year":"2017","unstructured":"Santini A, Ronchi D, Garbellini M, Piga D, Protti A (2017) Linezolid-induced lactic acidosis: the thin line between bacterial and mitochondrial ribosomes. Expert Opin Drug Saf 16:833\u2013843. https:\/\/doi.org\/10.1080\/14740338.2017.1335305","journal-title":"Expert Opin Drug Saf"},{"key":"3221_CR28","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1111\/jcpt.13245","volume":"45","author":"Y Dai","year":"2020","unstructured":"Dai Y, Wang Y, Zeng Y, Zhang C, Zhou Z, Shi D (2020) Linezolid and the risk of lactic acidosis: data mining and analysis of the FDA Adverse Event Reporting System. J Clin Pharm Ther 45:1422\u20131426. https:\/\/doi.org\/10.1111\/jcpt.13245","journal-title":"J Clin Pharm Ther"},{"key":"3221_CR29","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1708\/3202.31796","volume":"54","author":"A Cuomo","year":"2019","unstructured":"Cuomo A, Ballerini A, Bruni AC, Decina P, Di Sciascio G, Fiorentini A, Scaglione F, Vampini C, Fagiolini A (2019) Clinical guidance for the use of trazodone in major depressive disorder and concomitant conditions: pharmacology and clinical practice. Riv Psichiatr 54:137\u2013149. https:\/\/doi.org\/10.1708\/3202.31796","journal-title":"Riv Psichiatr"},{"key":"3221_CR30","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1056\/NEJMoa1515725","volume":"375","author":"RM Navari","year":"2016","unstructured":"Navari RM, Qin R, Ruddy KJ, Liu H, Powell SF, Bajaj M, Dietrich L, Biggs D, Lafky JM, Loprinzi CL (2016) Olanzapine for the prevention of chemotherapy-induced nausea and vomiting. N Engl J Med 375:134\u2013142. https:\/\/doi.org\/10.1056\/NEJMoa1515725","journal-title":"N Engl J Med"},{"key":"3221_CR31","doi-asserted-by":"publisher","first-page":"32020","DOI":"10.1074\/jbc.M114.594796","volume":"289","author":"JD Hothersall","year":"2014","unstructured":"Hothersall JD, Alexander A, Samson AJ, Moffat C, Bollan KA, Connolly CN (2014) 5-Hydroxytryptamine (5-HT) cellular sequestration during chronic exposure delays 5-HT3 receptor resensitization due to its subsequent release. J Biol Chem 289:32020\u201332029. https:\/\/doi.org\/10.1074\/jbc.M114.594796","journal-title":"J Biol Chem"},{"key":"3221_CR32","doi-asserted-by":"publisher","unstructured":"Watanabe N, Omori IM, Nakagawa A, Cipriani A, Barbui C, Churchill R, Furukawax TA (2011) Mirtazapine versus other antidepressive agents for depression. Cochrane Database Syst Rev. 12:CD006528. https:\/\/doi.org\/10.1002\/14651858.CD006528.pub2","DOI":"10.1002\/14651858.CD006528.pub2"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-021-03221-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-021-03221-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-021-03221-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T08:03:30Z","timestamp":1641801810000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-021-03221-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,28]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["3221"],"URL":"https:\/\/doi.org\/10.1007\/s00228-021-03221-x","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,28]]},"assertion":[{"value":"25 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of the Hokkaido University Hospital for Clinical Research (study protocol no. 019\u20130213).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}